Press Releases

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its fourth quarter and fiscal year 2014 on Thursday, August 14, 2014 at approximately 8:00 a.m....

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug...

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen...

Perrigo Company plc (NYSE: PRGO; TASE) and its partner, Catalent, announced today that they have settled their first to file Hatch Waxman litigation with Teva with respect to a generic version of...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2,...

Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for azelastine...

Fiscal third quarter net sales increased 9% year-over-year to a record $1,004 million. Fiscal third quarter adjusted net income increased 31% to $176 million, or $1.31 per diluted share; GAAP net...

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on June 17, 2014 to shareholders of record on May 30, 2014.

Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation and help track and neutralize...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its third quarter fiscal year 2014 on Wednesday, May 7, 2014 at approximately 8:00 a.m. (ET). The...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic version of...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Nutritionals segment is partnering with KanPak LLC to manufacture store brand adult...

PetArmor®, a brand of Sergeant's Pet Care Products, Inc., is best known for flea and tick pet protection, but its mission extends beyond products....

Committed to its mission of helping dogs live happier, healthier lives, Sergeant's Pet Care Products, Inc., a leader in the pet supplies industry,...

Sergeant's Pet Care Products, Inc., a leader in the pet supplies industry, showcased a variety of innovative product offerings at the 2014 Global Pet...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the generic...

Perrigo Company plc (NYSE: PRGO; TASE) announced today that it entered into a series of agreements with existing collaboration partner, Transition...

Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the RBC Capital Markets' Global...

Sergeant's Pet Care Products, Inc., a leader in the pet supplies industry, announces the launch of its SENTRY Clean Up™ stain and odor remover product...

Oral hygiene is tied directly to your pet's overall health. In fact, studies show that keeping your pet's mouth healthy may increase their life...

Fiscal second quarter net sales increased 11% year-over-year to a record $979 million. Fiscal second quarter adjusted net income increased 45% to a record $185...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on March 18,...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its abbreviated...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2014 on Thursday, February...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application ("ANDA") for fluocinonide...

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will hold its Investor Day from 8:00 AM to approximately 12:00 PM EST on February 28, at the...

Perrigo Company plc (NYSE: PRGO) today announced the appointment of its Board of Directors, effective until Perrigo Company's annual general meeting...

Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a...

Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...

Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all of its...

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...

Perrigo Company (NYSE: PRGO; TASE), a leading global healthcare supplier ("Perrigo") today announced that, at a shareholder meeting held today,...

Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on December...

The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches...

Perrigo Company (NYSE: PRGO; TASE) today announced results for its first quarter ended September 28, 2013. (Logo: ...

In the news release, Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013, issued Oct. 24, 2013 by Perrigo Company over PR Newswire, we are advised by the company...

Perrigo Company (NYSE, TASE: PRGO) today announced that it has scheduled a shareholder meeting for Monday, November 18, 2013 in connection with...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for nitroglycerin...

PetArmor®, known for its veterinarian-quality products that protect dogs and cats from fleas and ticks, is now also helping to protect four legged K-9s...

Perrigo Company (NYSE: PRGO; TASE) today announced the appointment of Keith Webber as Head of Regulatory Review, effective October 21, 2013. This...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its...

Perrigo Company (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley Global...

Perrigo Company (NYSE: PRGO; TASE: PRGO) today announced results for its fourth quarter and fiscal year ended June 29, 2013. (Logo:...

Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on September...

Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic...

Perrigo Company (NYSE: PRGO; TASE) today announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of...

Perrigo Company (NYSE: PRGO, "Perrigo") today announced that it it will release financial results for its fourth quarter and fiscal year 2013 and...